Cargando…
Pharmacogenetics of Anti-Diabetes Drugs
A variety of treatment modalities exist for individuals with type 2 diabetes mellitus (T2D). In addition to dietary and physical activity interventions, T2D is also treated pharmacologically with nine major classes of approved drugs. These medications include insulin and its analogues, sulfonylureas...
Autores principales: | DiStefano, Johanna K., Watanabe, Richard M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951319/ https://www.ncbi.nlm.nih.gov/pubmed/20936101 http://dx.doi.org/10.3390/ph3082610 |
Ejemplares similares
-
Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002) -
Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications
por: Leti, Fatjon, et al.
Publicado: (2017) -
Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013) -
Pharmacogenetics of Drugs Used in the Treatment of Cancers
por: Franczyk, Beata, et al.
Publicado: (2022) -
Pharmacogenetics of novel glucose-lowering drugs
por: Rathmann, Wolfgang, et al.
Publicado: (2021)